Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephanie Meyer
Stephanie Meyer
Sanofi Pasteur
Dengue vaccine
Vaccination
Antibody titer
Dengue fever
Immunogenicity
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines.
2021
Pediatric Infectious Disease Journal
Jaime Santos
May Montellano
Rontgene Solante
Nicole Perreras
Stephanie Meyer
Myew-Ling Toh
Céline Zocchetti
Claire Vigne
César Mascareñas
Show All
Source
Cite
Save
Citations (0)
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9-13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study.
2021
Pediatric Infectious Disease Journal
Jamiyah Hassan
Teck-Hock Toh
Selva Kumar Sivapunniam
Ruziaton Hasim
Nor Faizah Ghazali
Sofiah Sulaiman
Mia Tuang Koh
Stephanie Meyer
Myew-Ling Toh
Céline Zocchetti
Claire Vigne
César Mascareñas
Show All
Source
Cite
Save
Citations (0)
Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico.
2021
Vaccine
José Luis Arredondo
Sandra Martínez
María Concepción Morales
Stephanie Meyer
Myew-Ling Toh
Céline Zocchetti
Claire Vigne
César Mascareñas
Show All
Source
Cite
Save
Citations (0)
1
map